We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+7.55%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$201M
AUM Growth
-$24.7M
Cap. Flow
-$35.3M
Cap. Flow %
-17.56%
Top 10 Hldgs %
29.72%
Holding
72
New
14
Increased
15
Reduced
25
Closed
16

Top Buys

Rank Stock Value
1
SYK icon
Stryker
SYK
+$5.59M
2
MRK icon
Merck
MRK
+$5.02M
3
JNJ icon
Johnson & Johnson
JNJ
+$4.55M
4
GSK icon
GSK
GSK
+$4.21M
5
ESRX
Express Scripts Holding Company
ESRX
+$4.04M

Top Sells

Rank Stock Value
1
MCK icon
McKesson
MCK
+$8.02M
2
UNH icon
UnitedHealth
UNH
+$8M
3
AET
Aetna Inc
AET
+$7.46M
4
WBA
Walgreens Boots Alliance
WBA
+$5.9M
5
ABT icon
Abbott
ABT
+$5.23M

Sector Composition

Rank Sector Weight
1 Healthcare 89.51%
2 Energy 1.94%
3 Financials 1.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDVN
26
DELISTED
MEDIVATION, INC.
MDVN
$3.62M 1.8%
60,000
+15,000
+33% +$851K
HUM icon
27
Humana
HUM
$46.3B
$3.6M 1.79%
20,000
-15,000
-43% -$2.66M
ALXN
28
DELISTED
Alexion Pharmaceuticals
ALXN
$3.5M 1.74%
30,000
-20,000
-40% -$2.84M
REGN icon
29
Regeneron Pharmaceuticals
REGN
$83.2B
$3.49M 1.74%
10,000
-2,500
-20% -$963K
CHE icon
30
Chemed
CHE
$7.18B
$3.41M 1.69%
25,000
-15,000
-38% -$1.99M
BDX icon
31
Becton Dickinson
BDX
$48.9B
$3.39M 1.69%
20,500
-25,625
-56% -$4.1M
SCAI
32
DELISTED
Surgical Care Affiliates, Inc.
SCAI
$3.34M 1.66%
70,000
+10,000
+17% +$462K
AZN icon
33
AstraZeneca
AZN
$251B
$3.32M 1.65%
+55,000
New +$3.19M
BMRN icon
34
BioMarin Pharmaceuticals
BMRN
$13.3B
$3.11M 1.55%
40,000
-20,000
-33% -$1.7M
AMSG
35
DELISTED
Amsurg Corp
AMSG
$3.1M 1.54%
40,000
+5,000
+14% +$387K
GILD icon
36
Gilead Sciences
GILD
$165B
$3.05M 1.52%
36,617
-28,383
-44% -$2.52M
AMED
37
DELISTED
Amedisys
AMED
$3.03M 1.51%
60,000
-9,821
-14% -$496K
INCY icon
38
Incyte
INCY
$24.6B
$2.8M 1.39%
35,000
+5,000
+17% +$388K
GWPH
39
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$2.75M 1.37%
30,000
+10,000
+50% +$842K
WCG
40
DELISTED
Wellcare Health Plans, Inc.
WCG
$2.68M 1.33%
25,000
-25,000
-50% -$2.45M
RVTY icon
41
Revvity
RVTY
$12.9B
$2.62M 1.3%
50,000
+20
+0% +$1.05K
WMGI
42
DELISTED
Wright Medical Group Inc
WMGI
$2.61M 1.3%
+150,000
New +$2.75M
CI icon
43
Cigna
CI
$73.6B
$2.56M 1.27%
20,000
-20,000
-50% -$2.64M
HRC
44
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$2.33M 1.16%
46,126
-1,874
-4% -$94.4K
DPLO
45
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$2.27M 1.13%
+65,000
New +$2.04M
UNH icon
46
UnitedHealth
UNH
$371B
$2.12M 1.05%
15,000
-60,000
-80% -$8M
WAT icon
47
Waters Corp
WAT
$40.4B
$2.11M 1.05%
15,000
-5,000
-25% -$676K
JAZZ icon
48
Jazz Pharmaceuticals
JAZZ
$16.7B
$1.91M 0.95%
+13,500
New +$1.99M
ACAD icon
49
Acadia Pharmaceuticals
ACAD
$5.06B
$1.87M 0.93%
57,500
-42,500
-43% -$1.42M
CYH icon
50
Community Health Systems
CYH
$415M
$1.81M 0.9%
150,000
-49,650
-25% -$727K
1
2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
EWP
Evergreen Wealth Partners Kalispell, Montana $131M AUM
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return

Sivik Global Healthcare's Q2 2016 Portfolio in Review

As of Q2 2016, Sivik Global Healthcare held 72 positions worth $201M, down 11% from $226M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Sivik Global Healthcare withdrew a net $35.3M in Q2 2016, closing 16 positions and reducing 25 holdings. Its most notable exit was McKesson, an estimated $8.02M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 87% a quarter earlier, followed by Energy and Financials.

Against the trend, Sivik Global Healthcare opened a new position in Stryker worth $5.99M.

  • Sivik Global Healthcare's largest Q2 2016 buy was Stryker: 50,000 shares worth $5.99M.
  • Sivik Global Healthcare added most to Vertex Pharmaceuticals in Q2 2016, an estimated $3.89M increase.
  • Sivik Global Healthcare's biggest Q2 2016 reduction was UnitedHealth, cutting an estimated $8M.
  • Sivik Global Healthcare fully exited McKesson in Q2 2016, selling an estimated $8.02M.
  • Sivik Global Healthcare's ten largest holdings make up 30% of its $201M portfolio in Q2 2016.
  • Sivik Global Healthcare opened 14 new positions and closed 16 in Q2 2016.
  • Sivik Global Healthcare's portfolio value fell 11% quarter-over-quarter to $201M.

Based on Sivik Global Healthcare's 13F filing for Q2 2016, filed 5 Aug 2016.